4
Changes in Ownership
Immunocore Holdings plc Filed Acc 0001955244-25-000005
HEAD OF R&D sold 22,732 shares at an average $35.66 ($810,701)
- HEAD OF R&D acquired 22,732 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Berman David M · HEAD OF R&D
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +22,532 | $17.46 | $393,409 | 22,532 | D |
| 2025-09-12 | Sale : show line 2 in the form 10b5-1 | −21,232 | $35.63 | $756,496 | 1,300 | D |
| 2025-09-12 | Sale : show line 3 in the form 10b5-1 | −1,300 | $36.31 | $47,203 | 0 | D |
| 2025-09-15 | Exercise or conversion : show line 4 in the form 10b5-1 | +200 | $17.46 | $3,492 | 200 | D |
| 2025-09-15 | Sale : show line 5 in the form 10b5-1 | −200 | $35.01 | $7,002 | 0 | D |
| Open-market sales · 22,732 sh · avg $35.66 · $810,701 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-12 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Share Option (Right to Buy) | −22,532 | 198,839 | D |
| 2025-09-15 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Share Option (Right to Buy) | −200 | 198,639 | D |
Loading xslF345X05/form4-09162025_040906.xml…